Trademark: 88842050
Word
HALOVAX
Status
Dead
Status Code
602
Status Date
Tuesday, February 1, 2022
Serial Number
88842050
Mark Type
4000
Filing Date
Friday, March 20, 2020
Published for Opposition
Tuesday, July 21, 2020
Abandoned Date
Monday, January 24, 2022

Trademark Owner History
Voltron Therapeutics, Inc. - Owner At Publication

Classifications
5 Vaccine adjuvants; Vaccine preparations; Vaccine stabilizers; Vaccines; Vaccines against flu; Vaccines against pneumococcal infections; Human vaccine preparations; Oral vaccine preparations; Therapeutic vaccines

Trademark Events
Feb 1, 2022
Abandonment Notice E-Mailed - Failure To Respond
Feb 1, 2022
Abandonment - Failure To Respond Or Late Response
Jul 21, 2021
Notification Of Final Refusal Emailed
Jul 21, 2021
Final Refusal E-Mailed
Jul 21, 2021
Su - Final Refusal - Written
Jul 15, 2021
Teas/Email Correspondence Entered
Jul 15, 2021
Correspondence Received In Law Office
Jul 14, 2021
Assigned To Lie
Jun 8, 2021
Teas Response To Office Action Received
Mar 29, 2021
Notification Of Non-Final Action E-Mailed
Mar 29, 2021
Non-Final Action E-Mailed
Mar 29, 2021
Su - Non-Final Action - Written
Mar 6, 2021
Statement Of Use Processing Complete
Feb 17, 2021
Use Amendment Filed
Mar 6, 2021
Case Assigned To Intent To Use Paralegal
Feb 17, 2021
Teas Statement Of Use Received
Sep 15, 2020
Noa E-Mailed - Sou Required From Applicant
Jul 21, 2020
Official Gazette Publication Confirmation E-Mailed
Jul 21, 2020
Published For Opposition
Jul 1, 2020
Notification Of Notice Of Publication E-Mailed
Jun 17, 2020
Approved For Pub - Principal Register
Jun 12, 2020
Assigned To Examiner
Mar 25, 2020
New Application Office Supplied Data Entered
Mar 24, 2020
New Application Entered

Trademark Alertz updated from USPTO on 2030-01-24